Paolo Manca
Overview
Explore the profile of Paolo Manca including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
68
Citations
714
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Faletra F, La Franca E, Mule M, Carvelli A, Parisi F, Di Stefano G, et al.
Echocardiography
. 2025 Feb;
42(3):e70101.
PMID: 39998385
Functional mitral regurgitation (FMR) is a complex left ventricle (LV) and left atrium (LA) disorder in which mitral valve regurgitation is just the "tip of the iceberg." Unlike primary mitral...
2.
Matassini M, Manca P, Limonta R, Marini M, Orso F, Carigi S, et al.
G Ital Cardiol (Rome)
. 2025 Feb;
26(3):173-184.
PMID: 39998347
Heart failure (HF) is a clinical syndrome with high morbidity and mortality, characterized by periods of relative clinical stability and exacerbations of HF, known as worsening heart failure (WHF). WHF...
3.
Parlati A, Madaudo C, Nuzzi V, Manca P, Gentile P, Di Lisi D, et al.
Card Fail Rev
. 2025 Feb;
11:e01.
PMID: 39981305
Congestion in patients with heart failure (HF) predicts adverse outcomes and is a leading cause of hospitalisation. Understanding congestion mechanisms helps in HF management and underscores the importance of tailored...
4.
Faletra F, Sgarito G, Parisi F, La Franca E, Mule M, Carvelli A, et al.
Cardiovasc Ultrasound
. 2025 Feb;
23(1):2.
PMID: 39956911
Mitral valve prolapse (MVP) is a common condition affecting approximately 3% of the population, typically with a benign clinical course. However, a small subset of patients (5-10%) may develop severe...
5.
Tinti M, De Gennaro L, DElia E, Benvenuto M, Cittar M, Limonta R, et al.
G Ital Cardiol (Rome)
. 2024 Dec;
26(1):38-49.
PMID: 39714499
Mineralocorticoid receptor antagonists (MRAs) represent one of the cornerstones of treatment for heart failure with reduced ejection fraction. Post-hoc data from the TOPCAT trial, conducted in patients with heart failure...
6.
Pietrantonio F, Morano F, Niger M, Ghelardi F, Chiodoni C, Palazzo M, et al.
Clin Cancer Res
. 2024 Dec;
31(4):649-658.
PMID: 39620921
Purpose: Novel combinations are required to overcome resistance to immune checkpoint inhibitors in proficient mismatch repair (pMMR) or microsatellite-stable (MSS) metastatic colorectal cancer (mCRC). We aimed to determine whether vorbipiprant,...
7.
8.
Nuzzi V, Manca P, Mule M, Leone S, Fazzini L, Cipriani M, et al.
Heart Fail Rev
. 2024 Sep;
29(6):1247-1260.
PMID: 39298044
Echocardiography represents an essential tool for imagers and clinical cardiologists in the management of patients with heart failure. Advanced heart failure (AdHF) is a more severe and, typically, later stage...
9.
Gui C, Walch H, Mueller K, Boe L, Ilica A, Strong J, et al.
J Neurosurg
. 2024 Aug;
142(2):443-453.
PMID: 39213675
Objective: Brain metastases (BM) from colorectal cancer (CRC) are associated with dismal prognosis. When BM-directed therapy is considered, better methods are needed to identify patients at risk of poor oncological...
10.
Nuzzi V, Manca P, Parisi F, Madaudo C, Sciacca S, Cannizzo N, et al.
Curr Probl Cardiol
. 2024 Aug;
49(11):102823.
PMID: 39208997
Aims: Sodium-glucose cotransporter inhibitors (SGLT2-i) improve outcomes in patients with heart failure (HF) and reduced ejection fraction (HFrEF). However, evidence in patients with advanced HF is lacking. We aimed to...